ID: ALA350524

Max Phase: Preclinical

Molecular Formula: C4H8O3

Molecular Weight: 104.11

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  O[C@@H]1COC[C@H]1O

Standard InChI:  InChI=1S/C4H8O3/c5-3-1-7-2-4(3)6/h3-6H,1-2H2/t3-,4-/m1/s1

Standard InChI Key:  SSYDTHANSGMJTP-QWWZWVQMSA-N

Associated Targets(non-human)

Beta-glucosidase 120 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Beta-galactosidase 1278 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: YesOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 104.11Molecular Weight (Monoisotopic): 104.0473AlogP: -1.26#Rotatable Bonds: 0
Polar Surface Area: 49.69Molecular Species: NEUTRALHBA: 3HBD: 2
#RO5 Violations: 0HBA (Lipinski): 3HBD (Lipinski): 2#RO5 Violations (Lipinski): 0
CX Acidic pKa: 13.06CX Basic pKa: CX LogP: -1.31CX LogD: -1.31
Aromatic Rings: 0Heavy Atoms: 7QED Weighted: 0.40Np Likeness Score: 1.15

References

1. Field RA, Haines AH, Chrystal EJ.  (1991)  The Interaction of Anhydroalditols with Sweet-Almond -glucosidase and Escherichia coli -galactosidase: implications for the design of potent glycosidase inhibitors,  (12): [10.1016/S0960-894X(01)81044-1]

Source